Navigation Links
Confusion Prevails Over the Risk and Benefits of Hormone Therapy

Hormone therapy mainly consisted of Estrogen-only or estrogen plus progestin. It was mainly prescribed for women treat menopausal symptoms//. It was originally prescribed to quell hot flashes and other symptoms of menopause, but there were also indications that the therapy lowered the risks of heart disease, bone loss and possibly other ailments. Hormone replacement therapy came under scrutiny when research called the Women's Health Initiative study was terminated early, in February 2004, because of unexpected findings that women faced heightened risks of ailments including stroke, blood clots and breast cancer. Since then, further analysis of the WHI study data and other studies has generated confusion.

But a recent study said that hormone replacement therapy used to treat symptoms of menopause does not raise the risk of breast cancer for women who have had a hysterectomy. The finding contrasts with the higher risk of breast cancer among menopausal women taking estrogen plus progestin which is a combination designed to protect against uterine cancer. In hysterectomy all or part of the uterus is removed. Dr. Elizabeth Nabel, director of the National Heart, Lung, and Blood Institute of the National Institutes of Health, which sponsored the WHI study said that hormone therapy should only be used to treat menopausal symptoms and should be used at the smallest effective dose for the shortest possible time. After the WHI study was published, sales of Wyeth's leading hormone replacement drugs Premarin and Prempro fell dramatically.

A new study done by Marcia Stefanik of Stanford University was published in the Journal of the American Medical Association, covered nearly 11,000 women participating in the WHI study who had a hysterectomy. It was found that there were fewer breast cancers diagnosed for women on the active study pills when compared to those taking harmless sugar pills. But the tumors were significantly larger and had a tendency to spread to more lymph nodes. The women taking estrogen had slightly fewer breast cancers but they had more follow-up mammograms and biopsies performed. The hormone tends to make breast tissue denser and therefore more difficult to detect tumors. Hence there still exists some sort of confusion over the effectiveness and safety of the therapy.


'"/>




Related medicine news :

1. Drug Name Confusion Makes Imports Dangerous: FDA
2. Confusion persists in the case of whole grains
3. To Eat Or Not To Eat: Confusion Over Tandoori Chicken
4. Cancer Confusion over Kylie effect
5. Kerala: God’s Own Country Prevails Against AID
6. Benefits in fertility procedures
7. Benefits of Vitamin Supplements Unclear
8. Benefits of Eating Whole Grains, Fruits and Vegetables
9. Benefits of Nitric Oxide in the Treatment of Premature Infants
10. Benefits and Risks of Asthma Treatment Questioned
11. Benefits Of The Worlds Most Widely Used Beverage
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/27/2016)... ... 2016 , ... This campaign aims to provide a path to improved education ... control and change. , As nearly 795,000 Americans suffering from a new or recurrent ... Plus, with an estimated 129,000 of these people dying from stroke, it’s become our ...
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... ... Mediaplanet to help educate the many who are unaware of the plight of ... aphasia will run within the “Stroke Awareness” campaign. , The link between stroke ...
(Date:5/27/2016)... ... 27, 2016 , ... Aimed at nurses and employees in ... courtesy of leaders in the nursing and health care industry. It also provides ... and associations—namely Jones & Bartlett Learning. , Jones & Bartlett Learning is adding ...
(Date:5/27/2016)... ... May 27, 2016 , ... Each year Standard ... Allison Outerbridge is this year’s Life University winner of a $2,500 ... university’s Student Leadership Awards ceremony. , Outerbridge is approaching her last quarter at ...
(Date:5/26/2016)... ... , ... Despite last week’s media reports hinting at a June rate hike ... March 2017 for an interest rate increase, according to Rajeev Dhawan of the Economic ... Federal Open Market Committee (FOMC) dot charts are of interest to the press for ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... Amarantus BioScience Holdings, Inc. ... Regenerative Medicine, Neurology and Orphan Diseases, today announced that President & ... upcoming investor conferences: SeeThru Equity MicroCap Conference   ... New York City , NY When: Tuesday, May ... Conference   Where: Grand Hyatt Hotel, 109 East 42 ...
(Date:5/26/2016)... May 26, 2016   Change Healthcare ... analytics, network solutions and technology-enabled services designed ... entered into a strategic channel partnership with ... software solutions and revenue cycle management services ... and rehabilitation clinics to optimize revenue, operational ...
(Date:5/25/2016)... and GERMANTOWN, Maryland , May 25, 2016 ... ; Frankfurt Prime Standard: QIA) today announced that the company ... Diagnostics GmbH to develop and commercialize predictive assays in oncology. ... as a marker to predict effectiveness of anthracycline treatment in ... "We are pleased to partner with Therawis, which developed the ...
Breaking Medicine Technology: